Muscular Dystrophy Association Advocacy
Muscular Dystrophy Association Celebrates Historic Advancements in Accessible Air Travel as Congress Passes FAA Reauthorization
15 mai 2024 14h57 HE | Muscular Dystrophy Association
Washington, D.C., May 15, 2024 (GLOBE NEWSWIRE) -- Today, the Muscular Dystrophy Association (MDA) celebrates a landmark achievement in accessible air travel as Congress grants final passage to the...
ALS Super Fund Announcement
United for a Cure: ALS Super Fund, backed by Canadian NHL teams, hits $1 Million With Charitable Impact’s Cause Fund
14 mai 2024 16h28 HE | Charitable Impact
VANCOUVER, BC, May 14, 2024 (GLOBE NEWSWIRE) -- With tremendous support from Canada's seven National Hockey League (NHL) teams, individuals and several communities, the ALS Super Fund has achieved a...
AB Science:
AB Science:
07 mai 2024 12h05 HE | AB Science
COMMUNIQUE DE PRESSE UNE NOUVELLE PUBLICATION DANS LA REVUE MÉDICALE MUSCLE & NERVE VALIDE L’UTILISATION DU DECLIN DU SCORE ALSFRS-R (ΔFS) POUR LE DESIGN DES ETUDES CLINIQUES ET LE CHOIX DE...
AB Science : A new p
AB Science : A new publication in the medical journal Muscle & Nerve validates the use of the rate of decline of ALSFR-S score (ΔFS) for the design of clinical studies and the treatment choice for amyotrophic lateral sclerosis (ALS) patient
07 mai 2024 12h05 HE | AB Science
PRESS RELEASE A NEW PUBLICATION IN THE MEDICAL JOURNAL MUSCLE & NERVE VALIDATES THE USE OF THE RATE OF DECLINE OF ALSFRS-R SCORE (ΔFS) FOR THE DESIGN OF CLINICAL STUDIES AND THE TREATMENT CHOICE...
End ALS with Muscular Dystrophy Association
Muscular Dystrophy Association Launches ALS Awareness Month with Public Service Announcement ‘Answering the Call’
29 avr. 2024 09h00 HE | Muscular Dystrophy Association
New York, April 29, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today announced programming and fundraising events in support of people living with Amyotrophic Lateral...
Muscular Dystrophy Association Advocacy
Muscular Dystrophy Association Launches ‘Access The Vote’ Campaign to Amplify Rights of Accessible Voting
23 avr. 2024 08h49 HE | Muscular Dystrophy Association
Washington, D.C., April 23, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) is proud to announce the launch of its latest MDA Advocacy initiative, the ‘Access The Vote’ Campaign,...
Muscular Dystrophy Association Celebrates 70 Years of Partnership with International Association of Fire Fighters
International Association of Fire Fighters & Affiliates Launch ‘Fill the Boot’ Fundraisers Nationwide for Muscular Dystrophy Association
10 avr. 2024 09h00 HE | Muscular Dystrophy Association
New York, April 10, 2024 (GLOBE NEWSWIRE) -- Muscular Dystrophy Association (MDA) celebrates 70 years of partnership with the International Association of Fire Fighters (IAFF) kicking off more...
AB Science annonce q
AB Science annonce que Santé Canada a jugé admissible la demande de réexamen du masitinib dans SLA
03 avr. 2024 12h09 HE | AB Science
COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE QUE SANTÉ CANADA A JUGÉ ADMISSIBLE LA DEMANDE DE RÉEXAMEN DU MASITINIB DANS LA SCLÉROSE LATÉRALE AMYOTROPHIQUE Paris, 3 avril 2024, 18h AB Science SA...
AB Science announces
AB Science announces that Health Canada has granted eligibility for reconsideration request for masitinib in ALS
03 avr. 2024 12h09 HE | AB Science
PRESS RELEASE AB SCIENCE ANNOUNCES THAT HEALTH CANADA HAS GRANTED ELIGIBILITY FOR RECONSIDERATION REQUEST FOR MASITINIB IN AMYOTROPHIC LATERAL SCLEROSIS Paris, 3 April, 2024,...
Athira Pharma Logo RGB@1200px.jpg
Athira Pharma Announces Upcoming Poster Presentation at American Academy of Neurology (AAN) 2024 Annual Meeting
03 avr. 2024 07h00 HE | Athira Pharma, Inc.
BOTHELL, Wash., April 03, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing novel small molecules to restore neuronal...